Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT05616598

Effect of New Oral Treatment for Hepatitis C Virus on Seminal Parameters

Conditions: Male Infertility, HCV

Sex: Male

Ages: 18 Years – 55 Years

Healthy volunteers: 1

Phase: PHASE2, PHASE3

Enrollment: 200

Sponsor: Benha University

Location: Egypt

Summary

Hepatitis C virus is commona viral infection. Direct-acting antiviral (DAA) oral drugs has been used in treatment of HCVs. the effect of these drugs on male infertility is still under investigation.

Eligibility Criteria

Inclusion Criteria:Men patients with HCVExclusion Criteria:Patients with other hepatic disease, endocrinal disorder, malignancy, or urinary tract infection.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05616598). StuddyBuddy aggregates publicly available trial information.